221 related articles for article (PubMed ID: 36436119)
1. Tumor-suppressive E3 ubiquitin ligase CHIP inhibits the PBK/ERK axis to repress stem cell properties and radioresistance in non-small cell lung cancer.
Tan B; Zhang J; Wang W; Ma H; Yang Y
Apoptosis; 2023 Apr; 28(3-4):397-413. PubMed ID: 36436119
[TBL] [Abstract][Full Text] [Related]
2. SOX2 Promotes Radioresistance in Non-small Cell Lung Cancer by Regulating Tumor Cells Dedifferentiation.
Wang S; Li Z; Li P; Li L; Liu Y; Feng Y; Li R; Xia S
Int J Med Sci; 2023; 20(6):781-796. PubMed ID: 37213675
[No Abstract] [Full Text] [Related]
3. E3 Ubiquitin Ligase CHIP Inhibits the Interaction between Hsp90
Tan B; Zhang J; Wang W; Ma H; Yang Y
Stem Cells Int; 2022; 2022():2760899. PubMed ID: 36199626
[TBL] [Abstract][Full Text] [Related]
4. E3 ubiquitin ligase FBXW7 enhances radiosensitivity of non-small cell lung cancer cells by inhibiting SOX9 regulation of CDKN1A through ubiquitination.
Zhu H; Wang X; Zhou X; Lu S; Gu G; Liu C
Lab Invest; 2022 Nov; 102(11):1203-1213. PubMed ID: 35840806
[TBL] [Abstract][Full Text] [Related]
5. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
[TBL] [Abstract][Full Text] [Related]
6. A novel role for NFIA in restoring radiosensitivity in radioresistant NSCLC cells by downregulating the AKT and ERK pathways.
Sun C; Li Y; Tan Y; Zhang H; Liang Y; Zeng J; Yu J; Zou H
Biochem Biophys Res Commun; 2019 Aug; 515(4):558-564. PubMed ID: 31178144
[TBL] [Abstract][Full Text] [Related]
7. The E3 Ligase CHIP Mediates p21 Degradation to Maintain Radioresistance.
Biswas K; Sarkar S; Du K; Brautigan DL; Abbas T; Larner JM
Mol Cancer Res; 2017 Jun; 15(6):651-659. PubMed ID: 28232384
[TBL] [Abstract][Full Text] [Related]
8. Mogrol-mediated enhancement of radiotherapy sensitivity in non-small cell lung cancer: a mechanistic study.
Yin Z; Zhang X; Sun X; Huo Y; Ji N; Chen K
Am J Physiol Cell Physiol; 2024 Jun; 326(6):C1753-C1768. PubMed ID: 38682239
[TBL] [Abstract][Full Text] [Related]
9. UBR5 inhibits the radiosensitivity of non-small cell lung cancer cells via the activation of the PI3K/AKT pathway.
Gu YF; Ge XP
J Investig Med; 2021 Jun; 69(5):970-975. PubMed ID: 33811132
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy diagnostic biomarkers in radioresistant human H460 lung cancer stem-like cells.
Yun HS; Baek JH; Yim JH; Um HD; Park JK; Song JY; Park IC; Kim JS; Lee SJ; Lee CW; Hwang SG
Cancer Biol Ther; 2016; 17(2):208-18. PubMed ID: 26901847
[TBL] [Abstract][Full Text] [Related]
11. miR-219a-5p enhances the radiosensitivity of non-small cell lung cancer cells through targeting CD164.
Wei T; Cheng S; Fu XN; Feng LJ
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32364222
[TBL] [Abstract][Full Text] [Related]
12. CLPTM1L induces estrogen receptor β signaling-mediated radioresistance in non-small cell lung cancer cells.
Li H; Che J; Jiang M; Cui M; Feng G; Dong J; Zhang S; Lu L; Liu W; Fan S
Cell Commun Signal; 2020 Sep; 18(1):152. PubMed ID: 32943060
[TBL] [Abstract][Full Text] [Related]
13. Tumor suppressor miR-29c regulates radioresistance in lung cancer cells.
Arechaga-Ocampo E; Lopez-Camarillo C; Villegas-Sepulveda N; Gonzalez-De la Rosa CH; Perez-Añorve IX; Roldan-Perez R; Flores-Perez A; Peña-Curiel O; Angeles-Zaragoza O; Rangel Corona R; Gonzalez-Barrios JA; Bonilla-Moreno R; Del Moral-Hernandez O; Herrera LA; Garcia-Carranca A
Tumour Biol; 2017 Mar; 39(3):1010428317695010. PubMed ID: 28345453
[TBL] [Abstract][Full Text] [Related]
14. DCUN1D1 facilitates tumor metastasis by activating FAK signaling and up-regulates PD-L1 in non-small-cell lung cancer.
Li J; Yu T; Yan M; Zhang X; Liao L; Zhu M; Lin H; Pan H; Yao M
Exp Cell Res; 2019 Jan; 374(2):304-314. PubMed ID: 30528265
[TBL] [Abstract][Full Text] [Related]
15. USP9X-mediated REV1 deubiquitination promotes lung cancer radioresistance via the action of REV1 as a Rad18 molecular scaffold for cystathionine γ-lyase.
Chen Y; Feng X; Wu Z; Yang Y; Rao X; Meng R; Zhang S; Dong X; Xu S; Wu G; Jie X
J Biomed Sci; 2024 May; 31(1):55. PubMed ID: 38802791
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of ubiquitin inhibits the proliferation and radioresistance of non-small cell lung cancer cells in vitro and in vivo.
Tang Y; Geng Y; Luo J; Shen W; Zhu W; Meng C; Li M; Zhou X; Zhang S; Cao J
Sci Rep; 2015 Mar; 5():9476. PubMed ID: 25820571
[TBL] [Abstract][Full Text] [Related]
17. ITGB1 enhances the Radioresistance of human Non-small Cell Lung Cancer Cells by modulating the DNA damage response and YAP1-induced Epithelial-mesenchymal Transition.
Li Y; Sun C; Tan Y; Zhang H; Li Y; Zou H
Int J Biol Sci; 2021; 17(2):635-650. PubMed ID: 33613118
[No Abstract] [Full Text] [Related]
18. LncRNA SBF2-AS1 affects the radiosensitivity of non-small cell lung cancer via modulating microRNA-302a/MBNL3 axis.
Yu Z; Wang G; Zhang C; Liu Y; Chen W; Wang H; Liu H
Cell Cycle; 2020 Feb; 19(3):300-316. PubMed ID: 31928130
[No Abstract] [Full Text] [Related]
19. Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomas.
Amodio N; Scrima M; Palaia L; Salman AN; Quintiero A; Franco R; Botti G; Pirozzi P; Rocco G; De Rosa N; Viglietto G
Am J Pathol; 2010 Nov; 177(5):2622-34. PubMed ID: 20889565
[TBL] [Abstract][Full Text] [Related]
20. CHIP involves in non-small cell lung cancer prognosis through VEGF pathway.
Tingting Q; Jiao W; Qingfeng W; Yancheng L; Shijun YU; Zhaoqi W; Dongmei S; ShiLong W
Biomed Pharmacother; 2016 Oct; 83():271-276. PubMed ID: 27392029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
